Lv1
50 积分 2024-06-07 加入
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL
7小时前
求助中
Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease
8天前
已关闭
Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease
8天前
已关闭
Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease
8天前
已关闭
Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantation
3个月前
已完结
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
4个月前
已完结
Comparison of stem cell transplantation using unrelated, haploidentical, and sibling donors for patients with acquired severe aplastic anemia : A single center, retrospective, cohort study
4个月前
已完结
The role of donor type and pre‐transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia
4个月前
已完结
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
4个月前
已关闭
Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial
4个月前
已完结
皖公网安备34019202002308
